CClinicalTrials.gg
CompletedNCT02730520Updated Sep 12, 2016

Impact of Age on the Prevalence of Allergic Sensitization

An observational study in Allergy, sponsored by Brugmann University Hospital. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-09-12.

Sponsored by Brugmann University Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
1,400
Ages
18 Years and older
Sex
All
01

Study summary

Worldwide, respiratory diseases have a significant impact on morbidity and mortality of individuals.Tobacco, lifestyle and certain allergens such as dust mites play an important role in the prevalence and morbidity of these diseases. Scientific literature indicates that sensitization to allergens and respiratory diseases (asthma, rhinitis, chronic obstructive pulmonary disease) are closely linked. Moreover, smoking has an effect on allergen sensitivity.

To make a diagnosis of allergic sensitization, skin tests are performed in the patient. One of the methods used is the technique of "prick test". In practice, a drop of purified allergen extract is placed on the patient's skin (arms or back). A little dosis of the product is then injected in the epidermis. If fifteen minutes later, there is an edematous reaction, its diameter is measured in millimeters. From 4 mm, it is considered that the patient is sensitized to the tested foods or allergens.This technique is painless and convenient to patients of all ages, including newborns or conversely very aged patients.

This is a retrospective study based on the encoding and statistical analysis of data collected in patients followed within the Immuno-Allergology Service of the CHU Brugmann Hospital, who received an allergy assessment between 01/01/2015 and 31/12/2015. The allergens tested include: dermatophagoides pteronyssinus (DEPT), dermatophagoides farinae (DPF), blomia, cat, dog, cockroach, orchardgrass, timothy grass, alder, hazel,birch, olive tree, cypress, ash, latex, aspergillus, alternaria, cladosporium, peanut, hazel.

At least 1400 files will be analyzed.

Patients will be distributed in six age groups.The results of the allergen skin tests will be encoded as the edema diameter. The allergenicity score (mean of the skin reactivities for each allergen) will be compared between each age groups. The impact of tabagism, gender, BMI and residential area on the allergic reactivity will also be assessed in the overall population and within each age group.

The main objective is to evaluate the effect of age on the skin test positivity. The secondary objective is to highlight the environmental factors that have an impact on allergic diseases.

02

Conditions studied

  • Allergy

Keywords

  • respiratory disease
  • allergen sensitization
  • aging
  • skin tests
  • air allergens
03

In context

Lead sponsor

Brugmann University Hospital is the lead sponsor of 116 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients followed within the Immuno-Allergology Service of the CHU Brugmann Hospital, who received an allergy assessment between 01/01/2015 and 31/12/2015.

Inclusion criteria

  • All patients followed within the Immuno-Allergology Service of the CHU Brugmann Hospital
  • Who received an allergy assessment between 01/01/2015 and 31/12/2015. The allergens tested include: dermatophagoides pteronyssinus (DEPT), dermatophagoides farinae (DPF), blomia, cat, dog, cockroach, orchardgrass, timothy grass, alder, hazel,birch, olive tree, cypress, ash, latex, aspergillus, alternaria, cladosporium, peanut, hazel.

Exclusion criteria

Exclusion Criteria:

  • Negative histamine patients
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
1,400 participants (actual)
Patient registry
No

Groups and cohorts

  • Immuno-allergology patients

    Patients followed within the Immuno-Allergology Service of the CHU Brugmann Hospital, who received an allergy assessment between 01/01/2015 and 31/12/2015. At least 1400 dermis will be analyzed. The allergens tested include: dermatophagoides pteronyssinus (DEPT), dermatophagoides farinae (DPF), blomia, cat, dog, cockroach, orchardgrass, timothy grass, alder, hazel,birch, olive tree, cypress, ash, latex, aspergillus, alternaria, cladosporium, peanut, hazel.

    Other: Retrospective analysis of patient files

Interventions

  • OtherRetrospective analysis of patient files

    The results of the allergen skin tests will be encoded as the edema diameter. The allergenicity score (mean of the skin reactivities for each allergen) will be compared between each age groups. The impact of tabagism, gender, BMI and residential area on the allergic reactivity will also be assessed in the overall population and within each age group.

06

What researchers measure

Primary outcomes

  1. Allergenicity score

    Mean of the skin reactivities for each allergen. The results of the allergen skin tests are encoded as the edema diameter. Scores will be compared between the different age groups.

    Time frame: one year (01/01/2015 to 31/12/2015)

Secondary outcomes

  1. Smoking status

    Effect of the smoking/non smoking status on the allergic reactivity, analysed in the hole group and in the different age groups.

    Time frame: one year (01/01/2015 to 31/12/2015)

  2. Geographic localisation

    Effect of the area of residence on the allergic reactivity, analysed in the hole group and in the different age groups.

    Time frame: one year (01/01/2015 to 31/12/2015)

  3. Sex

    Gender effect on the allergic reactivity, analysed in the hole group and in the different age groups.

    Time frame: one year (01/01/2015 to 31/12/2015)

  4. Body Mass Index

    Effect of the body mass index on the allergic reactivity, analysed in the hole group and in the different age groups.

    Time frame: one year (01/01/2015 to 31/12/2015)

07

Study locations

1 site
  • CHU Brugmann
    Brussels, 1020, Belgium
08

References and documents

Publications

  • Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy. 2005 Mar;60(3):350-3. doi: 10.1111/j.1398-9995.2005.00751.x. PubMed 15679721 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 12, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02730520
Lead sponsor
Brugmann University Hospital
Responsible party
Olivier Michel (Head of clinic, Brugmann University Hospital) — Principal investigator
First posted
Apr 6, 2016
Start date
May 2016
Primary completion
Sep 2016
Completion
Sep 2016
Last update
Sep 12, 2016

Study contacts

Olivier Michel, MD
principal investigator · CHU Brugmann

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion